Antimicrobial Therapy for Psoriasis

Abstract

Get full access to this article

View all access options for this article.

References

Rosenberg

E.W.

, Skinner

R.B.

, Noah

P.W.

Anti-infectious therapy of psoriasis. In: Roenigk

H.H.

, Maibach

H.I.

, eds. Psoriasis. Third Ed. Marcel Dekker, Inc., New York; 1998: 373–382.

Takegami

K.T.

, Ross

S.O.

, Rosenberg

E.W.

. Antimicrobial treatment of psoriasis [abstract]. J Invest Dermatol 1992; 98: 607.

Rosenberg

E.W.

, Noah

P.W.

, Skinner

R.B.

. Microbial associations of 167 patients with psoriasis. Acta Derm Venereol (Stockh) 1989; Suppl. 146: 72–5.

Noah

P.W.

The role of microorganisms in psoriasis.

Sem Derm 1990; 9: 269–76.

Rosenberg

E.W.

, Noah

P.W.

, Skinner

R.B.

Microorganisms and psoriasis.

J National Med Assn 1994; 84: 305–310.

Rosenberg

E.W.

, Noah

P.W.

, Zanolli

M.D.

. Use of rifampin with penicillin and erythromycin in the treatment of psoriasis. J Am Acad Dermatol 1986; 14: 761–4.

Vincent

, Ross

J.B.

, Dalton

, Wort

A.J.

A therapeutic trial of the use of penicillin V or erythromycin with or without rifampin in the treatment of psoriasis.

J Am Acad Dermatol 1992; 26: 458–61.

Belew

P.W.

, Rosenberg

E.W.

, Skinner

R.B.

, Marley

W.M.

Endotoxemia in psoriasis [letter].

Arch Dermatol 1982; 118: 142–3.

Wachowiak

, Stryker

G.V.

, Marr

. The occurrence of Monilia in relation to psoriasis. Arch Dermatol 1929; 19: 713–731.

10.

Skinner

R.B.

, Rosenberg

E.W.

, Noah

P.W.

Psoriasis of the palms and soles is frequently associated with oropharyngeal Candida albicans.

Acta Derm Venereol (Stockh) 1994; Suppl. 186; 149–50.

11.

Crutcher

Rosenberg

E.W.

, Belew

P.W.

. Oral nystatin in the treatment of psoriasis [letter]. Arch Dermatol 1984; 120: 435–6.

12.

Guttman

Psoriasis treatable with antibiotics if microbial theory true [article].

In: Dermatology Times, 1999; 20(6): 14.

13.

Farr

P.M.

, Marcks

J.M.

, Krause

L.B.

, Shuster

Response of scalp psoriasis to oral ketoconazole.

Lancet 1985; 2(8461): 921–2.

14.

Gupta

A.K.

, Lynde

C.W.

, Lauzon

G.J.

. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. Br J Dermatol 1998; 138: 529–32.

15.

Yamamoto

, Katayama

, Nishioka

Psoriasis and hepatitis C virus.

Acta Derm Venereol (Stockh) 1995; 75: 482–3.

16.

Chouela

, Abeldafio

, Panetta

. Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Derm 1996; 35: 797–9.

17.

Kanazawa

, Aikawa

, Tsuda

. Hepatitis C virus infection in patients with psoriasis. Arch Dermatol 1996; 132: 1391–2.

18.

Burrow

N.P.

, Norris

P.G.

, Alexander

, Wreghitt

Chronic hepatitis C infection and psoriasis [letter].

Dermatology 1995; 190: 173.

19.

Taglione

, Vatteroni

M.L.

, Martini

. Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. J Rheumatology 1999; 26(2): 370–2.

20.

Favre

, Orth

, Majewski

. Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 1998; 110: 311–7.

21.

Majewski

, Favre

, Orth

, Jablonska

Is human papillomavirus type 5 the putative autoantigen involved in psoriasis [letter]?

J Invest Dermatol 1998; 111: 341–2.

22.

Townsend

B.L.

, Cohen

P.R.

, Duvic

Zidovudine for the treatment of HIV-negative patients with psoriasis: a pilot study.

J Am Acad Dermatol 1995; 32: 994–9.